<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03289078</url>
  </required_header>
  <id_info>
    <org_study_id>9846</org_study_id>
    <nct_id>NCT03289078</nct_id>
  </id_info>
  <brief_title>Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center</brief_title>
  <acronym>FONTCAUDE</acronym>
  <official_title>Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center, for Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FONTCAUDE's Vichy SPA center, Juvignac</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of functional improvement after spa therapy in Fontcaude center, for knee&#xD;
      osteoarthritis Background. Knee osteoarthritis is the first indication of spa therapy in&#xD;
      rheumatology. This therapeutic represents a non pharmacological treatment and is recommended&#xD;
      by OARSI.&#xD;
&#xD;
      In order to obtain agreement for spa therapy, the center Fontcaude, needs to show clinical&#xD;
      improvement for patients, as demonstrated in the Thermarthrose study. This center is near&#xD;
      Montpellier and could improve patients localised in this area.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: randomised prospective clinical trial of patients with knee osteoarthritis.&#xD;
&#xD;
      The spa therapy group received 18 days of therapy over 3 weeks. Patients in the control group&#xD;
      received 18 days of therapy over 3 weeks after the 6-month follow-up visit.&#xD;
&#xD;
      Follow-up was at 3 and 6 months, by a visit to the examination.&#xD;
&#xD;
      The hypothesis of our study is to demonstrate clinical improvement at six months. The main&#xD;
      endpoint is the number of patients achieving minimal clinically important improvement (MCII)&#xD;
      at 6 months, defi ned as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a&#xD;
      normalised Western Ontario and McMaster Universities osteoarthritis index function score.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No financing&#xD;
  </why_stopped>
  <start_date type="Anticipated">October 2017</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Achievement of minimal clinically important improvement (MCII) at 6 months</measure>
    <time_frame>30 months</time_frame>
    <description>The main endpoint is the number of patients achieving minimal clinically important improvement (MCII) at 6 months, defined as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Achievement of minimal clinically important improvement (MCII) at 3 months</measure>
    <time_frame>30 months</time_frame>
    <description>The second outcome measure is the number of patients achieving minimal clinically important improvement (MCII) at 3 months, defi ned as ≥19.9 mm on the visual analogue pain scale and/or ≥9.1 points in a normalised Western Ontario and McMaster Universities osteoarthritis index function score, and also the safety.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Thermal care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spa Treatment realised daily 6 days a week during 18 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spa Treatment</intervention_name>
    <description>The spa treatments will be realised daily 6 days a week and during 18 days. The care will be provided is : Swimming pool of mobilization by physical therapist (20 minutes daily, Cataplasms (10 minutes daily), Shower in the jet (10 minutes daily), Shower under affusion (10 minutes daily)</description>
    <arm_group_label>Thermal care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patient aged 40 to 75 years with radiologic and gonarthrosis radiologic et painful&#xD;
             gonarthrosis, unilateral ou bilateral, whatever is the radiographic stage&#xD;
&#xD;
          -  Patient presenting a EVA ≥3 with a corresponding radiology at least of 1year&#xD;
&#xD;
          -  Patient affiliated with a social security system&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Realization of a water cure in the last 6 months&#xD;
&#xD;
          -  Infiltration of the knee of less than 3 months&#xD;
&#xD;
          -  Impossibility to sign the informed consent or which for reasons geographical, social&#xD;
             or psychological could not be regularly followed,&#xD;
&#xD;
          -  Person major placed under guardianship or trusteeship,&#xD;
&#xD;
          -  Private person of freedom by court or administrative order, nobody being the object of&#xD;
             a legal protective measure,&#xD;
&#xD;
          -  Patient already included in an interventional clinical protocol,&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Contraindication in the water cure:&#xD;
&#xD;
               -  Severe change of the general state or debilitating afflictions&#xD;
&#xD;
               -  Acute affections and pushed acute(sharp) of the chronic affections&#xD;
&#xD;
               -  Grave cardiac insufficiency, unstable arterial high blood pressure&#xD;
&#xD;
               -  Severe renal or hepatic insufficiency&#xD;
&#xD;
               -  Not healed cutaneous hurts&#xD;
&#xD;
               -  Contagious or evolutionary diseases&#xD;
&#xD;
               -  Evolutionary Cancers&#xD;
&#xD;
               -  Current immunomodulator or immunosupressor Treatment, waves of inflammation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabel TAVARES, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Montpellier</affiliation>
  </overall_official>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 18, 2017</study_first_submitted>
  <study_first_submitted_qc>September 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2017</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

